Company Filing History:
Years Active: 1996-2006
Title: Innovations of David H Chantry
Introduction
David H Chantry is a notable inventor based in Seattle, WA. He has made significant contributions to the field of chemokines, particularly through his work on the Macrophage Derived Chemokine (MDC). With a total of 7 patents, Chantry's innovations have the potential to impact therapeutic applications significantly.
Latest Patents
Among his latest patents, Chantry has developed purified and isolated polynucleotide sequences encoding a novel macrophage-derived C-C chemokine designated 'Macrophage Derived Chemokine' (MDC). His inventions include MDC analogs, MDC inhibitor substances, and methods for their production. These patents also cover antibodies reactive with the chemokine and assays for identifying modulators of MDC chemokine activity. His work provides valuable materials and methods for both recombinant and synthetic production of the chemokine and its analogs.
Career Highlights
David H Chantry is currently associated with Icos Corporation, where he continues to advance his research in the field of chemokines. His career is marked by a commitment to innovation and the development of therapeutic solutions.
Collaborations
Chantry has collaborated with notable colleagues such as Merl F Hoekstra and Patrick W Gray, contributing to a dynamic research environment that fosters innovation.
Conclusion
David H Chantry's work in the field of chemokines exemplifies the impact of innovative research on therapeutic applications. His contributions continue to pave the way for advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.